Literature DB >> 29694950

Is Sclerostin Level Associated with Cardiovascular Diseases in Hemodialysis Patients?

Gokce Kundakci Gelir1, Sule Sengul2, Gokhan Nergizoglu2, Sehsuvar Ertürk2, Neval Duman2, Sim Kutlay2.   

Abstract

BACKGROUND/AIMS: The objective of this study is to evaluate the relation between sclerostin, arterial stiffness, and cardiovascular events (CVE) in hemodialysis patients (HD).
METHODS: Sclerostin level and carotid-femoral pulse wave velocity (PWV) in 97 HD patients and sclerostin level in 40 controls were measured.
RESULTS: Sclerostin level was significantly higher in patients than in controls. Sclerostin associated positively with age, male gender, cardiovascular disease, statin use, BMI, and PWV while negatively with alkaline phosphatase, parathormone (PTH), Kt/V, cinacalcet and vitamin D use in univariable correlation analyses. Sclerostin associated positively with male gender and statin use but negatively with PTH in multivariate regression analyses. During observation, 30 fatal or nonfatal CVEs were observed. While univariate correlation analysis showed a positive association between PWV and sclerostin, there was no relation between the two in multivariate regression analysis.
CONCLUSION: Further studies are needed to understand the role of sclerostin in predicting PWV changes in HD patients.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Arterial stiffness; Hemodialysis; Sclerostin

Mesh:

Substances:

Year:  2018        PMID: 29694950     DOI: 10.1159/000487223

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  3 in total

1.  Associations of serum sclerostin and Dickkopf-related protein-1 proteins with future cardiovascular events and mortality in haemodialysis patients: a prospective cohort study.

Authors:  Eirini Stavrinou; Pantelis A Sarafidis; Charalampos Loutradis; Evangelos Memmos; Danai Faitatzidou; Panagiotis Giamalis; Charalampos Koumaras; Asterios Karagiannis; Aikaterini Papagianni
Journal:  Clin Kidney J       Date:  2020-08-31

2.  Meta-analysis of the association between sclerostin level and adverse clinical outcomes in patients undergoing maintenance haemodialysis.

Authors:  Sha-Sha Li; Zhi-Qin Zhang; Da-Wei He; Ao-Lin He; Qi-Feng Liu
Journal:  Ther Adv Chronic Dis       Date:  2021-08-27       Impact factor: 5.091

3.  Association of sclerostin with cardiovascular events and mortality in dialysis patients.

Authors:  Yun Zou; Min Yang; Jiao Wang; Li Cui; Zhenxing Jiang; Jiule Ding; Min Li; Hua Zhou
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.